![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Quest Diagnostics Launches New Digital Dementia Assessment
Quest Diagnostics Launches New Digital Dementia Assessment
![](https://www.fdanews.com/ext/resources/test/Device_Images4/EKGGreenandRedLines.gif?t=1433941185&width=430)
Quest Diagnostics has released Cognisense, a digital assessment tool that aids in a physician's care of individuals with cognitive dysfunction.
The tool is designed to provide practitioners with a digital method to evaluate the conceptual health of a patient's brain through the use of memory recall and comprehension techniques.
Cognisense was unveiled during the Alzheimer's Association International Conference in Toronto in July 2016. — Cynthia Jessup
Upcoming Events
-
21Oct